KPC PHARMACEUTICALS, INC. — Investor Relations & Filings
About KPC PHARMACEUTICALS, INC.
KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 昆药集团关于召开2024年年度股东大会的通知 | 2025-05-29 | Chinese | |
| 昆药集团十一届五次董事会决议公告 | 2025-05-29 | Chinese | |
| 昆药集团关于召开2025年第一季度业绩说明会的公告 | 2025-05-21 | Chinese | |
| 昆药集团关于参加云南辖区上市公司2024年度投资者网上集体接待日活动的公告 | 2025-05-12 | Chinese | |
| 昆药集团2025年第一季度报告 | 2025-04-28 | Chinese | |
| 昆药集团十一届四次董事会决议公告 | 2025-04-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40929268 | 昆药集团关于召开2024年年度股东大会的通知 | 2025-05-29 | Chinese | ||
| 40929257 | 昆药集团十一届五次董事会决议公告 | 2025-05-29 | Chinese | ||
| 40929247 | 昆药集团关于召开2025年第一季度业绩说明会的公告 | 2025-05-21 | Chinese | ||
| 40929237 | 昆药集团关于参加云南辖区上市公司2024年度投资者网上集体接待日活动的公告 | 2025-05-12 | Chinese | ||
| 40929225 | 昆药集团2025年第一季度报告 | 2025-04-28 | Chinese | ||
| 40929211 | 昆药集团十一届四次董事会决议公告 | 2025-04-28 | Chinese | ||
| 40929198 | 昆药集团十一届四次监事会决议公告 | 2025-04-28 | Chinese | ||
| 40929186 | 昆药集团2024年年度报告（修订版） | 2025-04-23 | Chinese | ||
| 40929124 | 北京德恒（昆明）律师事务所关于昆药集团股份有限公司2025年第三次临时股东大会的法律意见 | 2025-04-18 | Chinese | ||
| 40929112 | 昆药集团2025年第三次临时股东大会决议公告 | 2025-04-18 | Chinese | ||
| 40929097 | 昆药集团2025年第三次临时股东大会会议资料 | 2025-04-10 | Chinese | ||
| 40929074 | 昆药集团关于高级管理人员辞职的公告 | 2025-03-27 | Chinese | ||
| 40929061 | 昆药集团关于控股股东的间接控股股东华润医药集团有限公司刊发2024年业绩公告的提示性公告 | 2025-03-26 | Chinese | ||
| 40929051 | 昆药集团关于召开2024年度业绩说明会的公告 | 2025-03-25 | Chinese | ||
| 40929044 | 昆药集团十一届三次监事会决议公告 | 2025-03-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
KPC PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56720/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56720 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56720 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56720 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56720}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KPC PHARMACEUTICALS, INC. (id: 56720)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.